Posts Tagged: The Hospital for Sick Children (SickKids)

Bedside Clinical Systems aims to bring better healthcare to children

Each year, 5,000 children in North American hospitals experience code-blue incidents; a code blue is an event where patients require immediate resuscitation. One quarter of these incidents result in death, and Bedside Clinical Systems (BCS) seeks to drastically improve this statistic by launching its flagship solution, Bedside Paediatric Early Warning System (BedsidePEWS™). “BedsidePEWS™ is a unique software solution that helps hospital clinicians to identify deteriorating children early, giving them a window of opportunity to intervene and potentially avoid code blue incidents,” says Rajesh ... Read more

Business Without Borders highlights ScarX Therapeutics’ Chinese co-development partnership

ScarX Therapeutics, a spin-off company created by MaRS Innovation and The Hospital for Sick Children (SickKids), was profiled by Business Without Borders on September 25, 2012. Sean Fine's article examines the strategic funding partnership MI pursued with NovoTek Therapeutics Inc. (NovoTek) in China to develop the anti-scarring cream, which was discovered by researchers at SickKids. A multibillion-dollar market may await ScarX, a Toronto biomedical start-up, but first it had to figure out how to finance the development of its unique cream that reduces scarring ... Read more

OtoSim Inc. Makes a Sound Pitch on BNN

OtoSim Inc., a MaRS Innovation spin-off company, made its debut on Business News Network’s The Pitchon June 1, 2012. Louis Hui, OtoSim’s business development manager, had 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts. (more…) Read more

OtoSim Inc. to Appear on BNN’s The Pitch

OtoSim Inc., a MaRS Innovation spin-off company, is taping an appearance on Business News Network’s The Pitch on May 22, 2012. Louis Hui, OtoSim’s business development manager, will have 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts. (more…) Read more

ScarX Therapeutics Featured on Front Page of the Globe and Mail

MaRS Innovation's ScarX Therapeutics, a strategic partnership with The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek), was featured on the front page of the Globe and Mail on May 7, 2010. Read the article on Globe and Mail.com (note that depending on when you're accessing this page, the Globe's content may be subject to a pay wall). (more…) Read more

MaRS Innovation Forms Strategic Drug-Development Partnership with NovoTek Therapeutics Inc. in China

MaRS Innovation (MI), The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek)  have announced a strategic partnership to co‐develop, and bring to the Chinese market, a novel therapeutic cream aimed at reducing scar formation post surgery. This project was covered in The Globe and Mail on May 7, 2012. (more…) Read more

OtoSim Inc. launches revolutionary simulator-training system to improve otoscopic diagnostic efficiency

MaRS Innovation provided crucial commercialization funding to support research from The Hospital for Sick Children MaRS Innovation (MI) and The Hospital for Sick Children (SickKids) have launched OtoSim Inc. to commercialize an otoscopy training system and process developed by two otolaryngologists at SickKids. The new product, the OtoSim™ program and training device, is the first in a series of training systems directed at improving the accuracy of ear examinations. Using simulation-based training is part of a wider trend in medicine. In otoscopy, healthcare professionals ... Read more
Page 3 of 3123